APPLICATION OF ERITROPOETIN OR ERITROPOETIN DERIVATIVES FOR THE TREATMENT OF CEREBRAL ISCHAEMIA

摘要

The invention relates to a method and agent for the treatment of cerebral ischaemia and to an agent for the treatment of cerebral ischaemia, notably by humans, of the kind seen, for example, in stroke patients. Surprisingly it was found that the peripheral administration of erythroprotein to ischaemia cerebral tissue has a marked protective effect. Erythroprotein dramatically reduces the area of permanently damaged cerebral tissue, notably in the penumbra, in comparison to results obtained with conventional measures without administration of erythroprotein.